Stockreport

A Look At IDEAYA Biosciences (IDYA) Valuation After New DLL3 Combo Trial Progress And Early Responses [Yahoo! Finance]

IDEAYA Biosciences, Inc.  (IDYA) 
Last ideaya biosciences, inc. earnings: 3/24 06:00 am Check Earnings Report
PDF IDEAYA Biosciences (IDYA) is back in focus after reporting the first patient has been treated in a Phase 1 trial that combines IDE849 and IDE161 in DLL3 upregulated sol [Read more]